Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pathologie-Biologie|September 10, 2013
[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy]R Duléry, C Giraud, J-L Beaumont, et al.European Journal of Haematology|May 23, 2024
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention studyN Mauz, M Bouisse, J Y Cahn, et al.Journal De Mycologie Medicale|November 27, 2012
[Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection]J-P Gangneux, C-C Adjidé, L Bernard, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2011
Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: a relationship?M-P Brenier-Pinchart, B Lebeau, J-L Borel, et al.Bone Marrow Transplantation|October 27, 2015
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working PartiesO Penack, G Tridello, J Hoek, et al.Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.Revue Neurologique|June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]S Guiu, S Taillibert, O Chinot, et al.Leukemia & Lymphoma|July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapyX Thomas, Qh Le, S de Botton, et al.Public Health Nutrition|March 18, 2003
Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC)P Ferrari, N Slimani, A Ciampi, et al.Pageof 3